Dengue fever, spread by mosquitoes, has emerged as one of the world's most significant
infectious diseases. To replicate and generate more copies of itself inside the host cell, the …

Dengue virus enters the cell by receptor-mediated endocytosis followed by a viral envelope
(DENVE) protein-mediated membrane fusion. A small detergent molecule n-octyl-β-D …

Dengue virus (DENV) has been characterized as having great clinical importance in the
world, as there is no specific treatment against this virus. The NS2B-NS3pro complex is …

Dengue virus is transmitted to human by mosquitoes. The virus has the potential to expand
globally and is responsible for a wide range of clinical manifestations which result in an …

The rising incidence of dengue virus (DENV) infections in the tropical and sub-tropical
regions of the world emphasizes the need to identify effective therapeutic drugs against the …

Dengue virus is an important class of virus of the Flavivirus family that is accountable for the
major cause of dengue fever, which could progress to dengue shock syndrome (DSS) which …

Dengue virus (DENV) is a family member of flaviviruses, transfer their pathogenecity to
humans by the vector mosquitoes and it is showing similar positive sense genomic RNA as …

Dengue fever is a severe, widespread disease with more than 2 million diagnosed infections
per year. The Dengue virus protease represents a cardinal target for prudent drug design …

Dengue is an acute febrile illness caused by the Dengue virus (DENV), with a high number
of cases worldwide. There is no available treatment that directly affects the virus or the viral …

Dengue virus (DENV) infection is one of the largest threats worldwide, and there is no any
specific drug available in the market to combat its serious causes. In the present study, we …